Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Republic of Korea.
Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3029-34. doi: 10.1007/s10096-012-1657-z. Epub 2012 Jun 2.
The clinical implication of extended-spectrum cephalosporin (ESC) resistance has been unclear in patients with Streptococcus pneumoniae meningitis (SPM). We collected the clinical data of 120 patients with SPM in 12 hospitals of the Republic of Korea. The clinical characteristics and outcomes of 23 ESC-nonsusceptible SPM episodes were compared to those of 97 ESC-susceptible episodes. Hospital acquisition, presence of other foci of pneumococcal infection, septic shock at initial presentation, or concomitant bacteremia were more commonly observed in ESC-nonsusceptible than ESC-susceptible SPM. Empiric antimicrobial therapy with vancomycin and ESC combination was very common in both groups. Although there was a tendency towards higher early fatality in ESC-nonsusceptible SPM (3-day mortality; 17.4 % vs. 4.4 %, p = 0.05), in-hospital mortality (26.1 % vs. 20.9 %, p = 0.59) and median length of hospital stay (20 days vs. 24 days, p = 0.34) did not differ between ESC-nonsusceptible and ESC-susceptible SPM.
对于肺炎链球菌性脑膜炎(SPM)患者,超广谱头孢菌素(ESC)耐药的临床意义尚不清楚。我们收集了韩国 12 家医院 120 名 SPM 患者的临床数据。将 23 例 ESC 耐药性 SPM 与 97 例 ESC 敏感性 SPM 进行比较,比较其临床特征和结局。ESC 耐药性 SPM 更常见于医院获得性、存在其他肺炎链球菌感染灶、初始表现为感染性休克或合并菌血症。两组患者经验性抗菌治疗均非常常见,采用万古霉素和 ESC 联合治疗。虽然 ESC 耐药性 SPM 的早期死亡率有升高趋势(3 天死亡率;17.4%比 4.4%,p=0.05),但 ESC 耐药性 SPM 与 ESC 敏感性 SPM 之间住院死亡率(26.1%比 20.9%,p=0.59)和中位住院时间(20 天比 24 天,p=0.34)并无差异。